Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Return on Sales (2016 - 2020)

Forte Biosciences (FBRX) has disclosed Return on Sales for 5 consecutive years, with 62.14% as the latest value for Q4 2020.

  • Quarterly Return on Sales rose 123803.0% to 62.14% in Q4 2020 from the year-ago period, while the trailing twelve-month figure was 62.14% through Dec 2020, up 137687.0% year-over-year, with the annual reading at 1764.33% for FY2019, 176162.0% down from the prior year.
  • Return on Sales for Q4 2020 was 62.14% at Forte Biosciences, down from 71.04% in the prior quarter.
  • The five-year high for Return on Sales was 90.51% in Q2 2020, with the low at 2178.11% in Q4 2018.
  • Average Return on Sales over 5 years is 666.49%, with a median of 51.57% recorded in 2019.
  • The sharpest move saw Return on Sales plummeted -208165bps in 2019, then soared 215271bps in 2020.
  • Over 5 years, Return on Sales stood at 16.21% in 2016, then plummeted by -6786bps to 1083.7% in 2017, then tumbled by -101bps to 2178.11% in 2018, then soared by 46bps to 1175.89% in 2019, then surged by 105bps to 62.14% in 2020.
  • According to Business Quant data, Return on Sales over the past three periods came in at 62.14%, 71.04%, and 90.51% for Q4 2020, Q3 2020, and Q2 2020 respectively.